Shortcuts

open access

Vol 3, No 3 (2004): Polish Palliative Medicine
Artykuły poglądowe
Published online: 2004-04-27
Get Citation

The involvement of cardiovascular system in patients with lung cancer

Piotr Sobański
Advances in Palliative Medicine 2004;3(3):265-280.

open access

Vol 3, No 3 (2004): Polish Palliative Medicine
Artykuły poglądowe
Published online: 2004-04-27

Abstract

Patients with malignant tumours of the lungs often present with symptoms and signs of cardiovascular pathology as well as with abnormal results of the diagnostic tests. In such situations oncologists are faced with difficult therapeutic decisions. These may concern qualification or disqualification for a particular modality of oncological treatment. Scrupulous assessment enables radical anti-tumoral treatment to be started. This also applies to patients with cardiovascular risk factors, provided, however, that the risk is relatively low and there is a real chance of survival of the period of active cardiological treatment. In patients with advanced disease, may become difficult. In such cases of advanced malignancy interventions should be limited to correction of the abnormalities, disapperance of which may improve the patient’s survival or quality of live. Sometimes it becomes difficult to find out which cardiovascular pathologies accompanying the malignancy are clinically significant. This article describes basic symptoms and signs, diagnostic and treatment modalities of the cardiovascular diseases caused by malignancy and also catalogues the cardiovascular side-effects of oncological treatment.

Abstract

Patients with malignant tumours of the lungs often present with symptoms and signs of cardiovascular pathology as well as with abnormal results of the diagnostic tests. In such situations oncologists are faced with difficult therapeutic decisions. These may concern qualification or disqualification for a particular modality of oncological treatment. Scrupulous assessment enables radical anti-tumoral treatment to be started. This also applies to patients with cardiovascular risk factors, provided, however, that the risk is relatively low and there is a real chance of survival of the period of active cardiological treatment. In patients with advanced disease, may become difficult. In such cases of advanced malignancy interventions should be limited to correction of the abnormalities, disapperance of which may improve the patient’s survival or quality of live. Sometimes it becomes difficult to find out which cardiovascular pathologies accompanying the malignancy are clinically significant. This article describes basic symptoms and signs, diagnostic and treatment modalities of the cardiovascular diseases caused by malignancy and also catalogues the cardiovascular side-effects of oncological treatment.
Get Citation

Keywords

lung cancer; cardiac metastases; pulmonary embolism; arrhythmias; pericarditis; tamponade

About this article
Title

The involvement of cardiovascular system in patients with lung cancer

Journal

Advances in Palliative Medicine

Issue

Vol 3, No 3 (2004): Polish Palliative Medicine

Pages

265-280

Published online

2004-04-27

Bibliographic record

Advances in Palliative Medicine 2004;3(3):265-280.

Keywords

lung cancer
cardiac metastases
pulmonary embolism
arrhythmias
pericarditis
tamponade

Authors

Piotr Sobański

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl